Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up

DNA methylation analysis of cervical scrapes using FAM19A4 and mir124‐2 genes has shown a good clinical performance in detecting cervical cancer and advanced CIN lesions in need of treatment in HPV‐positive women. To date, longitudinal data on the cancer risk of methylation test‐negative women are l...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Cancer
Päätekijät: De Strooper, Lise M.A., Berkhof, Johannes, Steenbergen, Renske D.M., Lissenberg‐Witte, Birgit I., Snijders, Peter J.F., Meijer, Chris J.L.M., Heideman, Daniëlle A.M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2018
Aiheet:
Cancer Therapy and Prevention
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6099282/
https://ncbi.nlm.nih.gov/pubmed/29663363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31539
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia